In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...

This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...

National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...

The Novartis research study is testing a potential new investigational treatment that is a single infusion of rapcabtagene autoleucel (also called rap-cel) for patients with active, refractory lupus ...

The Lupus Foundation of America’s (LFA) Community Health Worker (CHW) hub was created to increase awareness of lupus and knowledge of resources available. The CHW hub features on-demand learning ...

A new study found that low levels of 25-Hydroxyvitamin D levels are associated with significantly higher mortality and cardiovascular events in individuals with systemic lupus erythematosus (SLE).

A new study explored molecules carried within blood exosomes to see if changes in fat metabolism contribute to lupus.

Living with lupus can be stressful. And stress can trigger your lupus symptoms or make them worse. But you can take steps to manage stress and protect your health. Try these tips to manage stress when ...

Individuals and families managing lupus or other disabilities can access educational and financial support to help succeed in school and beyond. Schools may provide accommodations through 504 plans or ...

A new study looked at whether heart scan results can help predict serious cardiovascular or cerebrovascular (brain) events (MACCE) in people with systemic lupus erythematosus (SLE) and found a ...